Nishiwaki Satoshi, Terakura Seitaro, Ito Masafumi, Goto Tatsunori, Seto Aika, Watanabe Keisuke, Yanagisawa Mayumi, Imahashi Nobuhiko, Tsukamoto Shokichi, Shimba Makoto, Ozawa Yukiyasu, Miyamura Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Blood. 2009 Oct 1;114(14):3113-6. doi: 10.1182/blood-2009-03-209635. Epub 2009 Jul 30.
We retrospectively reviewed 104 biopsy specimens of previously untreated skin acute graft-versus-host disease (GVHD) within 100 days after allogeneic stem cell transplantation, and analyzed the relationship between types of infiltrating cells and clinical outcomes. Counting the total number of CD8(+) T cells, CD163(+) macrophages, and CD1a(+) dendritic cells in 4 fields under original magnification x200, the infiltration of more than 200 cells of CD163(+) macrophages (many macrophages [MM]) was the only significant predictor for refractory GHVD (odds ratio, 3.79; 95% confidence interval, 1.22-11.8; P = .02). In 46 patients given steroid treatments, MM was the only significant predictor for refractory acute GVHD (odds ratio, 5.05; 95% confidence interval, 1.19-21.3; P = .03). Overall survival of patients with MM was significantly lower than that of those with an infiltration of less than 200 cells of CD163(+) macrophages. Macrophage infiltration of skin lesions could be a significant predictive factor for refractory GVHD and a poor prognosis.
我们回顾性分析了104例异基因干细胞移植后100天内未经治疗的皮肤急性移植物抗宿主病(GVHD)活检标本,并分析了浸润细胞类型与临床结局之间的关系。在原始放大倍数为200倍的情况下,对4个视野中的CD8(+) T细胞、CD163(+)巨噬细胞和CD1a(+)树突状细胞总数进行计数,CD163(+)巨噬细胞浸润超过200个细胞(大量巨噬细胞[MM])是难治性GVHD的唯一显著预测指标(比值比,3.79;95%置信区间,1.22 - 11.8;P = 0.02)。在46例接受类固醇治疗的患者中,MM是难治性急性GVHD的唯一显著预测指标(比值比,5.05;95%置信区间,1.19 - 21.3;P = 0.03)。MM患者的总生存率显著低于CD163(+)巨噬细胞浸润少于200个细胞的患者。皮肤病变中的巨噬细胞浸润可能是难治性GVHD和预后不良的重要预测因素。